JY231(JY231) Injection for the Treatment of Relapsed/Refractory B Cell Lymphoma/ Leukemia

Clinical trial NCT06890065 · RECRUITING

Trial details

NCT number: NCT06890065
Sponsor: Shenzhen Genocury Biotech Co., Ltd.
Status: RECRUITING
Phase: Not Applicable
Study type: INTERVENTIONAL

B Acute Lymphoblastic Leukemia B-Non Hodgkin Lymphoma

Start date: 2025-03-01
Primary completion: 2027-12-01
Enrollment: 20

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.